# OnCo record clarity-gastric01 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/clarity-gastric01/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "clarity-gastric01", "NCT06346392" ;
  schema:name "CLARITY-Gastric 01"@en ;
  schema:description "The first ADC against Claudin 18.2 to prove it extends life, announced July 2026, giving stomach cancer its first ADC beyond HER2."@en ;
  schema:url <https://onco.cc/trials/clarity-gastric01/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06346392>, <https://ascopubs.org/doi/10.1200/JCO.2025.43.4_suppl.TPS507> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2024-03-04" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:drugs <https://onco.cc/drugs/cmg901/>, <https://onco.cc/drugs/ramucirumab/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .